1. Home
  2. EVO vs MMI Comparison

EVO vs MMI Comparison

Compare EVO & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evotec SE

EVO

Evotec SE

HOLD

Current Price

$3.00

Market Cap

934.1M

Sector

Health Care

ML Signal

HOLD

MMI

Marcus & Millichap Inc.

HOLD

Current Price

$28.75

Market Cap

1.1B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVO
MMI
Founded
1993
1971
Country
Germany
United States
Employees
4553
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
934.1M
1.1B
IPO Year
N/A
2013

Fundamental Metrics

Financial Performance
Metric
EVO
MMI
Price
$3.00
$28.75
Analyst Decision
Strong Buy
Sell
Analyst Count
1
2
Target Price
$7.00
$28.00
AVG Volume (30 Days)
107.1K
153.2K
Earning Date
04-08-2026
05-07-2026
Dividend Yield
N/A
1.76%
EPS Growth
N/A
84.38
EPS
N/A
N/A
Revenue
N/A
$719,700,000.00
Revenue This Year
$1.37
$14.04
Revenue Next Year
$10.05
$11.35
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.31
$24.43
52 Week High
$4.80
$33.62

Technical Indicators

Market Signals
Indicator
EVO
MMI
Relative Strength Index (RSI) 51.88 71.53
Support Level $2.87 $28.27
Resistance Level $3.78 $31.56
Average True Range (ATR) 0.10 0.55
MACD 0.02 0.16
Stochastic Oscillator 50.00 98.23

Price Performance

Historical Comparison
EVO
MMI

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

About MMI Marcus & Millichap Inc.

Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans. The Company has one reportable segment: commercial real estate services. The commercial real estate services segment is the aggregation of our two operating segments: investment sales and financing services.

Share on Social Networks: